CNO · Cno Financial Group, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.03B | - | $1.19B | $1.15B | $1.00B | - | $1.13B | $1.07B | $1.16B | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $83.40M | - | - | - | $77.80M | - | - | - | $70.40M | - |
| Operating Income | $129.90M | - | $162.80M | $112.30M | $104.60M | - | $153.50M | $148.60M | $74.80M | - |
| Interest Expense | $50.90M | - | $56.60M | $59.10M | $62.00M | - | $68.00M | $64.20M | $60.20M | - |
| Income Tax | $10.70M | - | $28.20M | $26.20M | $4.00M | - | $1.70M | $34.30M | $33.90M | - |
| Net Income | $37.70M | - | $23.10M | $91.80M | $13.70M | - | $9.30M | $116.30M | $112.30M | - |
| EPS - Basic | $0.40 | - | $0.24 | $0.93 | $0.14 | - | $0.09 | $1.08 | $1.03 | - |
| EPS - Diluted | $0.39 | - | $0.24 | $0.91 | $0.13 | - | $0.09 | $1.06 | $1.01 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.15B | $983.50M | $1.24B | $816.00M | $1.02B | $2.00B | $1.25B | $992.10M | $649.80M | $889.00M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $38.96B | $38.79B | $38.30B | $37.33B | $37.44B | $37.85B | $37.65B | $36.29B | $34.94B | $35.10B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $36.47B | $36.15B | $35.69B | $34.81B | $34.91B | $35.35B | $34.96B | $33.86B | $32.57B | $32.89B |
| Stockholders' Equity | $2.50B | $2.64B | $2.61B | $2.52B | $2.53B | $2.50B | $2.69B | $2.43B | $2.37B | $2.22B |
| Retained Earnings | $2.44B | $2.42B | $2.34B | $2.33B | $2.23B | $2.24B | $2.09B | $2.09B | $2.00B | $1.90B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $148.80M | - | - | - | $136.70M | - | - | - | $94.60M | - |
| Investing Cash Flow | ($184.10M) | - | - | - | ($538.20M) | - | - | - | ($23.60M) | - |
| Financing Cash Flow | $206.10M | - | - | - | ($571.40M) | - | - | - | ($310.20M) | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 12.6% | - | 13.7% | 9.8% | 10.4% | - | 13.6% | 13.9% | 6.5% | - |
| EBITDA margin | 20.7% | - | - | - | 18.2% | - | - | - | 12.6% | - |
| Net margin | 3.7% | - | 1.9% | 8.0% | 1.4% | - | 0.8% | 10.9% | 9.7% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 22.1% | - | 55.0% | 22.2% | 22.6% | - | 15.5% | 22.8% | 23.2% | - |
| Return on assets | 0.1% | - | 0.1% | 0.2% | 0.0% | - | 0.0% | 0.3% | 0.3% | - |
| Return on equity | 1.5% | - | 0.9% | 3.6% | 0.5% | - | 0.3% | 4.8% | 4.7% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 2.6x | - | 2.9x | 1.9x | 1.7x | - | 2.3x | 2.3x | 1.2x | - |
| Equity multiplier | 15.60 | 14.70 | 14.67 | 14.80 | 14.79 | 15.15 | 14.01 | 14.94 | 14.76 | 15.84 |
| Liabilities / Assets | 0.94 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.94 |
| Efficiency | ||||||||||
| Asset turnover | 0.03 | - | 0.03 | 0.03 | 0.03 | - | 0.03 | 0.03 | 0.03 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 105.3x | - | 164.8x | 42.4x | 320.4x | - | 390.0x | 26.2x | 27.2x | - |
| P / B | 1.6x | - | 1.5x | 1.5x | 1.7x | - | 1.4x | 1.2x | 1.3x | - |
| P / S | 3.8x | - | 3.3x | 3.4x | 4.3x | - | 3.3x | 2.8x | 2.6x | - |
| EV / EBITDA | 13.1x | - | - | - | 17.9x | - | - | - | 16.5x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 2.5% | - | 5.2% | 8.0% | -13.2% | - | 19.2% | 4.2% | 15.0% | - |
| Revenue CAGR (3y) | 0.8% | - | 9.5% | 10.4% | 6.0% | - | 5.3% | -0.2% | 4.8% | - |
| Revenue CAGR (5y) | 0.5% | - | 3.2% | 2.6% | 7.0% | - | 3.7% | 1.7% | 2.5% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 24.2% | - | 6.1% | -24.4% | 39.8% | - | 18.3% | 83.0% | -2.1% | - |
| Net income growth (YoY) | 175.2% | - | 148.4% | -21.1% | -87.8% | - | -94.4% | 57.8% | - | - |
| EPS growth (YoY) | 200.0% | - | 166.7% | -14.2% | -87.1% | - | -93.8% | 65.6% | - | - |
| EPS CAGR (3y) | - | - | -35.9% | -7.8% | -48.1% | - | -51.1% | 22.3% | -2.2% | - |
| EPS CAGR (5y) | -18.4% | - | -23.4% | 9.8% | - | - | -19.7% | 34.6% | 25.8% | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -1.3% | 5.6% | -2.9% | 3.9% | 6.9% | 12.8% | 42.2% | 21.7% | 16.5% | 58.2% |
Peer comparison
Same SIC group: Accident & Health Insurance
Comparing CNO Financial Group against the 4 most active filers in the same SIC group.
Dividends
$0.68/share trailing 12 months · +6.3% YoY
| Ex-date | Per share |
|---|---|
| Mar 10, 2026 | $0.1700 |
| Dec 10, 2025 | $0.1700 |
| Sep 10, 2025 | $0.1700 |
| Jun 10, 2025 | $0.1700 |
| Mar 10, 2025 | $0.1600 |
| Dec 10, 2024 | $0.1600 |
| Sep 10, 2024 | $0.1600 |
| Jun 10, 2024 | $0.1600 |
| Mar 7, 2024 | $0.1500 |
| Dec 7, 2023 | $0.1500 |
| Sep 7, 2023 | $0.1500 |
| Jun 8, 2023 | $0.1500 |
| Mar 9, 2023 | $0.1400 |
| Dec 8, 2022 | $0.1400 |
| Sep 8, 2022 | $0.1400 |
| Jun 9, 2022 | $0.1400 |
| Mar 9, 2022 | $0.1300 |
| Dec 9, 2021 | $0.1300 |
| Sep 9, 2021 | $0.1300 |
| Jun 9, 2021 | $0.1300 |
| Mar 9, 2021 | $0.1200 |
| Dec 9, 2020 | $0.1200 |
| Sep 9, 2020 | $0.1200 |
| Jun 9, 2020 | $0.1200 |